Abstract
Background
The relationship between thymidine phosphorylase (TP) and angiogenesis at the early stage of esophageal squamous cell carcinoma has been unclear.
Methods
Using 14 samples of normal squamous epithelium, 11 samples of low-grade intraepithelial neoplasia, and 64 samples of superficial esophageal cancer, microvessel density (MVD) was estimated using immunostaining for CD34 and CD105. TP expression was also evaluated in both cancer cells and stromal monocytic cells (SMCs). We then investigated the correlation between MVD and TP expression in both cancer cells and SMCs.
Results
On the basis of the above parameters, MVD was significantly higher in cancerous lesions than in normal squamous epithelium. In terms of CD34 and CD105 expression, MVD showed a gradual increase from normal squamous epithelium, to low-grade intraepithelial neoplasia, and then to M1 and M2 cancer, and M3 or deeper cancer. M1 and M2 cancer showed overexpression of TP in both cancer cells and SMCs. There was no significant correlation between TP expression in cancer cells and MVD estimated from CD34 (rS = 0.16, P = 0.21) or CD105 (rS = 0.05, P = 0.68) expression. Significant correlations were found between TP expression in SMCs and CD34-related (rS = 0.46, P < 0.001) and CD105-related (rS = 0.34, P < 0.01) MVD. In M3 or deeper cancers, there were no significant correlations between TP expression in cancer cells or SMCs and venous invasion, lymphatic invasion, and lymph node metastasis.
Conclusion
TP expression is activated in both cancer cells and stromal monocytic cells at the very early stage of ESCC progression. TP expression in SMCs, rather than in cancer cells, is significantly correlated with angiogenesis.
Similar content being viewed by others
Abbreviations
- M1:
-
Carcinoma in situ
- M2:
-
Tumor invasion to the lamina propria mucosae
- M3:
-
Tumor invasion to the muscularis mucosa
- SM1:
-
Tumor invasion to the upper third of the submucosal layer
- SM2:
-
Tumor invasion to the middle third of the submucosal layer
- SM3:
-
Tumor invasion to the lower third of the submucosal layer
References
The Japan Esophageal Society. Japanese Classification of Esophageal Cancer, tenth edition: part 1. Esophagus. 2009;6:1–25.
Oyama T, Inoue H, Arima M, et al. Prediction of the invasion depth of superficial squamous cell carcinoma based on microvessel morphology: magnifying endoscopic classification of the Japan Esophageal Society. Esophagus. 2016;13:138–45.
Kumagai Y, Inoue H, Nagai K, et al. Magnifying endoscopy, stereoscopic microscopy and the microvascular architecture superficial esophageal carcinoma. Endoscopy. 2002;34:369–75.
Kumagai Y, Kawada K, Yamazaki S, et al. Prospective replacement of magnifying endoscopy by a newly developed endocytoscope, the “GIF-Y0002”. Dis Esophagus. 2010;23:627–32.
Kumagai Y, Toi M, Kawada K, et al. Angiogenesis in superficial esophageal squamous cell carcinoma: magnifying endoscopic observation and molecular analysis. Dig Endosc. 2010;22:259–67.
Kumagai Y, Toi M, Inoue H. Dynamism of tumour vasculature in the early phase of cancer progression: outcomes from oesophageal cancer research. Lancet Oncol. 2002;3:604–10.
Kumagai Y, Sobajima J, Higashi M, et al. Angiogenesis in superficial esophageal squamous cell carcinoma: assessment of microvessel density based on immunostaining for CD34 and CD105. Jpn J Clin Oncol. 2014;44:526–33. doi:10.1093/jjco/hyu039 (Epub 2014 Apr 19).
Kumagai Y, Sobajima J, Higashi M, et al. Tumor-associated macrophages and angiogenesis in early stage esophageal squamous cell carcinoma. Esophagus. 2016;13:245–53.
Graves DT, Valente AJ. Monocyte chemotactic proteins from human tumor cells. Biochem Pharmacol. 1991;41:333–7 (Review).
Toi M, Ueno T, Matsumoto H, et al. Significance of thymidine phosphorylase as a marker of protumor monocytes in breast cancer. Clin Cancer Res. 1999;5:1131–7.
Liu J, Li Z, Cui J, et al. Cellular changes in the tumor microenvironment of human esophageal squamous cell carcinomas. Tumour Biol. 2012;33:495–505. doi:10.1007/s13277-011-0281-3 (Epub 2011 Dec 2).
O’Brien TS, Fox SB, Dickinson AJ, et al. Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers. Cancer Res. 1996;56:4799–804.
Yao Y, Kubota T, Sato K, et al. Macrophage infiltration-associated thymidine phosphorylase expression correlates with increased microvessel density and poor prognosis in astrocytic tumors. Clin Cancer Res. 2001;7:4021–6.
Igarashi M, Dhar DK, Kubota H, et al. The prognostic significance of microvessel density and thymidine phosphorylase expression in squamous cell carcinoma of the esophagus. Cancer. 1998;82:1225–32.
Koide N, Nishio A, Hiraguri M, et al. Differences and relationships of thymidine phosphorylase expression in tumor-associated macrophages and cancer cells in squamous cell carcinoma of the esophagus. Dis Esophagus. 2002;15:67–73.
Kimura Y, Morohashi S, Yoshizawa T, et al. Clinicopathological significance of vascular endothelial growth factor, thymidine phosphorylase, and microvessel density in colorectal cancer. Mol Med Rep. 2016;13:1551–7.
Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1–8.
Friedkin M, Roberts D. The enzymatic synthesis of nucleosides. J Biol Chem. 1954;207:254–6.
Reigner B, Verweij J, Dirix L, et al. Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients. Clin Cancer Res. 1998;4:941–8.
Toi M, Rahman MA, Bando H, et al. Thymidine phosphorylase (platelet-derived endothelial growth factor) in cancer biology and treatment. Lancet Oncol. 2005;6:158–66.
Usuki K, Saras J, Waltenberger J, et al. Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity. Biochem Biophys Res Commun. 1992;184:1311–6.
Brown NS, Bicknell R. Thymidine phosphorylase, 2-deoxy-d-ribose and angiogenesis. Biochem J. 1998;334:1–8 (Review).
Bijnsdorp IV, Capriotti F, Kruyt FA, et al. Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors. Br J Cancer. 2011;104:1185–92.
Takebayashi Y, Natsugoee S, Baba M, et al. Thymidine phosphorylase in human esophageal squamous cell carcinoma. Cancer. 1999;85:282–9.
Kitadai Y, Onogawa S, Kuwai T, et al. Angiogenic switch occurs during the precancerous stage of human esophageal squamous cell carcinoma. Oncol Rep. 2004;11:315–9.
Vartanian RK, Weidner N. Endothelial cell proliferation in prostatic carcinoma and prostatic hyperplasia: correlation with Gleason’s score, microvessel density, and epithelial cell proliferation. Lab Invest. 1995;73:844–50.
Giatromanolaki A, Koukourakis MI, Stathopoulos GP, et al. Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer. Oncol Res. 2000;12:33–41.
Elamin YY, Rafee S, Osman N, et al. Thymidine phosphorylase in cancer; Enemy or friend? Cancer Microenviron. 2016;9:33–43. doi:10.1007/s12307-015-0173-y (Epub 2015 Aug 23).
Duff SE, Li C, Jeziorska M, et al. Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy. Br J Cancer. 2003;89:426–30.
Acknowledgements
Youichi Kumagai received MEXT KAKENHI Grant number 26461047.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical Statement
All procedures followed were in accordance with the ethical standards of the committees responsible for human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent for inclusion of tissue samples in this study was obtained from all patients or their representatives.
Conflict of interest
Youichi Kumagai received MEXT KAKENHI Grant number 26461047.
Rights and permissions
About this article
Cite this article
Kumagai, Y., Tachikawa, T., Higashi, M. et al. Thymidine phosphorylase and angiogenesis in early stage esophageal squamous cell carcinoma. Esophagus 15, 19–26 (2018). https://doi.org/10.1007/s10388-017-0588-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10388-017-0588-2